Recombinant H3N2 New-York
Beta LifeScience
SKU/CAT #: BLIT-0734
Recombinant H3N2 New-York
Beta LifeScience
SKU/CAT #: BLIT-0734
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Tag | N/A |
Host Species | H3N2 |
Background | H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin(H) and neuraminidase(N). H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, and influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. |
Description | Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells and its Mw is 70,000 dalton. |
Source | Insect cells |
Purity | Greater than 90.0% as determined by SDS-PAGE. |
Formulation | The Recombinant H3N2 A/New-York/55/04 solution contains 10mM Sodium phosphate, pH 7.2 and 150mM NaCl. |
Applications | Antibody ELISA; immunogen; WB, etc. |
Usage | For Research Use Only |